标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | TWST | Twist Bioscience Corp | 102.48 | 0.68% |
| 2021-12-31 | MYGN | 万基遗传 | 101.89 | 0.67% |
| 2021-12-31 | RXRX | Recurison Pharmaceuticals Inc-A | 99.3 | 0.66% |
| 2021-12-31 | EDIT | Editas Medicine Inc | 100.7 | 0.66% |
| 2021-12-31 | SWTX | SpringWorks Therapeutics Inc | 97.37 | 0.64% |
| 2021-12-31 | TSVT | 2seventy bio Inc | 96.67 | 0.64% |
| 2021-12-31 | NVAX | 诺瓦瓦克斯医药 | 95.05 | 0.63% |
| 2021-12-31 | OCGN | Ocugen Inc | 93.57 | 0.62% |
| 2021-12-31 | CERE | Cerevel Therapeutics Holdings Inc | 91.46 | 0.6% |
| 2021-12-31 | ALLO | Allogene Therapeutics Inc | 91.04 | 0.6% |
| 2021-12-31 | INO | Inovio制药 | 90.89 | 0.6% |
| 2021-12-31 | AVXL | Anavex Life Sciences Corp | 87.88 | 0.58% |
| 2021-12-31 | ICPT | Intercept Pharmaceuticals Inc | 88.31 | 0.58% |
| 2021-12-31 | OPK | OPKO健康 | 85.99 | 0.57% |
| 2021-12-31 | ATRA | Atara Biotherapeutics Inc | 83.17 | 0.55% |
| 2021-12-31 | RVMD | Revolution Medicines Inc | 82.74 | 0.55% |
| 2021-12-31 | SRNE | Sorrento Therapeutics Inc | 82.51 | 0.54% |
| 2021-12-31 | MYOV | Myovant Sciences Ltd | 81.93 | 0.54% |
| 2021-12-31 | FGEN | FibroGen Inc | 79.7 | 0.53% |
| 2021-12-31 | RGNX | REGENXBIO Inc | 79.2 | 0.52% |
公告&资料
